Now let's explore how sirolimus and related compounds are used in cancer treatment.Sirolimus analogs, known as rapalogs, have been developed as cancer therapeutics with improved pharmacokinetic properties.Rapalogs primarily target mTORC1 while having limited effects on mTORC2, a key distinction that impacts their efficacy and resistance profiles.Several rapalogs have received FDA approval for specific cancer indications.Rapalogs work through multiple mechanisms to inhibit cancer growth and progression.Despite their efficacy, rapalogs face limitations due to resistance mechanisms.Research is advancing with next-generation mTOR inhibitors that target both mTORC1 and mTORC2 complexes.Combination therapy approaches are also being developed to overcome resistance mechanisms.To summarize, sirolimus and its analogs represent an important class of targeted cancer therapeutics, with ongoing research addressing their limitations.
Explore
Discover the full suite of AI-powered study tools designed to help you learn smarter.
Create notes from your material in seconds.
Take live notes and ask questions, hands-free.
Make flashcards from your material in one click.
Create and practice quizzes from your material.
Simulate the real exam with full-length tests.
Break your material into a clear learning path.
A real-time tutor that adapts to how you learn.
Talk to your personal AI tutor in real time.
Ask about the pictures and diagrams in your notes.
Call Spark.E to discuss your study material.
Turn your materials into a podcast or summary.
Grade essays with personalized feedback and tips.
Plan study sessions and hit your academic goals.
Play community-built study games or make your own.
